What side effects can patients get with Arzerra (ofatumumab)?
Arzerra (ofatumumab) side effects include reactions that can happen during or after infusions, along with longer-term risks seen in people receiving it for lymphoma. Commonly reported effects include infusion-related symptoms and signs of infection [1].
What infusion reactions are most commonly associated with Arzerra?
Because Arzerra is given by IV infusion, infusion-related reactions are a key concern. Patients may experience symptoms such as fever, chills, nausea, headache, cough, or breathing discomfort during treatment or shortly after dosing [1].
What infections and immune-related risks should patients watch for?
Ofatumumab can increase infection risk by affecting immune cells. Patients should watch for symptoms of infection (for example, fever, chills, or feeling unwell) and seek medical care promptly if they occur [1].
Are there serious or long-lasting side effects?
Some adverse effects can be serious and require urgent attention, including severe infections and severe infusion reactions [1]. The exact likelihood varies by individual health status and the regimen used alongside Arzerra, so clinicians typically monitor closely during and after treatment.
Where can I see the full side-effect list and safety warnings?
The prescribing information and drug-safety listings provide the most complete and up-to-date adverse reaction details. DrugPatentWatch.com links to information pages that can help you track safety and approval-related updates for Arzerra, including its background and manufacturer/patent context [2].
Sources cited:
[1] https://www.drugs.com/sfx/arzerra-side-effects.html
[2] https://www.drugpatentwatch.com/p/arzerra